Linked Data API

Show Search Form

Search Results

1135744
star this property registered interest false more like this
star this property date less than 2019-07-01more like thismore than 2019-07-01
star this property answering body
Ministry of Defence more like this
star this property answering dept id 11 more like this
star this property answering dept short name Defence more like this
star this property answering dept sort name Defence more like this
star this property hansard heading Malaria: Drugs remove filter
star this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords more like this
star this property question text To ask Her Majesty's Government whether the health and wellbeing of all participants in the Surgeon-General’s 2016–17 research study on anti-malarial chemoprophylaxis (Ref: 713/MoDREC/15) was monitored to ensure that all adverse events occurring during the study were reported to the Medicines and Healthcare products Regulatory Agency (MHRA); whether participants have been monitored following the study to ensure that any adverse events that have occurred since are being reported to the MHRA; and what assessment they have made of whether suitable treatment is available to those participants suffering adverse events. more like this
star this property tabling member printed
The Countess of Mar more like this
star this property uin HL16837 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2019-07-08more like thismore than 2019-07-08
star this property answer text <p>Adverse events are reported to the Medicines and Healthcare products Regulatory Agency (MHRA) using the Yellow card scheme and can be undertaken by a healthcare professional or the individual experiencing the adverse effect. The demographics required by the Yellow card scheme do not include the occupation of the subject, so military personnel are not uniquely identified.</p><p>The aims of the &quot;713/MoDREC/15&quot; study do not include assessing whether individuals or their healthcare professional reported side effects to the MHRA or to follow-up whether any person experiencing side effects required any form of treatment, including an assessment of whether suitable treatment was available. Data collated in the study is self-reported by individuals and any symptoms reported may not necessarily be related to the anti-malarial taken.</p> more like this
star this property answering member printed Earl Howe more like this
star this property question first answered
less than 2019-07-08T16:39:39.247Zmore like thismore than 2019-07-08T16:39:39.247Z
star this property answering member
2000
star this property label Biography information for Earl Howe remove filter
unstar this property tabling member
1861
unstar this property label Biography information for The Countess of Mar more like this